Oorsprong van het eerstegraads netwerk van Michael Serrano
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Sprout Bioventures
 Sprout Bioventures Investment ManagersFinance Sprout Bioventures (Sprout Bioventures) is a venture capital firm founded in 1900. The firm is headquartered in Cambridge, Massachusetts.
2
| Private Company | Investment Managers | 2 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Michael Serrano via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
Anji Pharmaceuticals, Inc.
 Anji Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anji Pharmaceuticals, Inc. engages in discovery and development of medicines for human genetics. The company is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chief Executive Officer | |
Dogma Therapeutics, Inc.
 Dogma Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Dogma Therapeutics, Inc. developing oral PCSK9 inhibitors to treat high cholesterol and cardiovascular disease. The company is headquartered in Boxford, MA. | Pharmaceuticals: Major | Chief Executive Officer | |
The Broad Institute, Inc.
 The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA. | Biotechnology | Director of Research - Equity | |
Merck Global Health Innovation LLC
 Merck Global Health Innovation LLC Investment ManagersFinance Merck Global Health Innovation LLC (Merck Global Health) is a venture capital subsidiary of Merck & Co., Inc. founded in 2010. The firm is headquartered in Rahway, New Jersey. | Investment Managers | Director of Research - Equity | |
| NOVARTIS AG | Pharmaceuticals: Major | Director of Research - Equity | |
| The College of William & Mary | College/University | Undergraduate Degree | |
| University of Illinois | College/University | Doctorate Degree | |
| Harvard Medical School | College/University | Graduate Degree | |
| UW Medicine | College/University | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 9 |
| Zwitserland | 2 |
Sectoraal
| Health Technology | 5 |
| Consumer Services | 5 |
| Finance | 2 |
Operationeel
| Director of Research - Equity | 3 |
| Private Equity Investor | 2 |
| Chief Executive Officer | 2 |
| Undergraduate Degree | 2 |
| Doctorate Degree | 1 |
Sterkste connecties
| Insiders | |
|---|---|
| Brian Hubbard | 9 |
| Dan Meyers | 2 |
- Beurs
- Insiders
- Michael Serrano
- Bedrijfsconnecties
